MIR5093: A Potential Drug Target and Biomarker (G100847022)

Target Name: MIR5093

NCBI ID: G100847022

MIR5093

Other Name(s): MicroRNA 5093 | microRNA 5093 | hsa-miR-5093 | hsa-mir-5093

MIR5093: A Potential Drug Target and Biomarker

MIR5093 is a protein that is expressed in various tissues of the body, including the lungs, heart, kidneys, and intestines. It is a member of the MIRASM gene family, which encodes for non-coding RNA-protein hybrids. MIR5093 has been shown to play a role in the regulation of cell proliferation, apoptosis, and inflammation. As a potential drug target and biomarker, MIR5093 is of interest to researchers due to its potential therapeutic applications in various diseases.

The MIRASM gene family has been identified as a potential drug target in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. MIR5093 is a member of the MIRASM gene family that has been shown to play a role in the regulation of cell apoptosis. During apoptosis, MIR5093 has been shown to be involved in the formation of apoptotic particles, which are composed of cellular debris that can be recognized by other cells as a potential danger signal.

MIR5093 has also been shown to be involved in the regulation of cell proliferation. It has been shown to promote the growth and proliferation of various cancer cell types, including breast, ovarian, and colorectal cancer. This suggests that MIR5093 may be a potential drug target for cancer therapies that target cell proliferation.

In addition to its potential therapeutic applications, MIR5093 is also a potential biomarker for various diseases. Its involvement in the regulation of cell apoptosis and proliferation makes it an attractive candidate for use as a biomarker for diseases that can be treated with drugs that target these processes. For example, MIR5093 has been shown to be involved in the regulation of cell apoptosis in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This suggests that MIR5093 may be a potential biomarker for these diseases and could be used as a target for diagnostic tests and therapies.

MIR5093 has also been shown to play a role in the regulation of inflammation. It has been shown to be involved in the regulation of immune cell function and the production of pro-inflammatory cytokines. This suggests that MIR5093 may be a potential drug target for diseases that are characterized by inflammation, such as rheumatoid arthritis, inflammatory bowel disease, and chronic obstructive pulmonary disease (COPD).

In conclusion, MIR5093 is a protein that has been shown to play a role in the regulation of cell apoptosis, proliferation, and inflammation. As a potential drug target and biomarker, MIR5093 is of interest to researchers due to its potential therapeutic applications in various diseases. Further research is needed to fully understand the role of MIR5093 in these processes and to explore its potential as a drug or biomarker.

Protein Name: MicroRNA 5093

The "MIR5093 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR5093 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets